|
1
|
Crook J: Long-term oncologic outcomes of
radical prostatectomy compared with brachytherapy-based approaches
for intermediate- and high-risk prostate cancer. Brachytherapy.
14:142–147. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mottet N, Bellmunt J, Bolla M, Briers E,
Cumberbatch MG, De Santis M, Fossati N, Gross T, Henry AM, Joniau
S, et al: EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1:
Screening, Diagnosis, and Local Treatment with Curative Intent. Eur
Urol. 71:618–629. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mohler JL, Armstrong AJ, Bahnson RR,
D'Amico AV, Davis BJ, Eastham JA, Enke CA, Farrington TA, Higano
CS, Horwitz EM, et al: Prostate cancer, Version 1.2106. J Natl
Compr Canc Netw. 14:19–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gómez-Veiga F, Rodríguez-Antolín A, Miñana
B, Hernández C, Suárez JF, Fernández-Gómez JM, Unda M, Burgos J,
Alcaraz A, Rodríguez P, et al GESCAP, : Diagnosis and treatment for
clinically localized prostate cancer. Adherence to the European
Association of Urology clinical guidelines in a nationwide
population-based study - GESCAP group. Actas Urol Esp. 41:359–367.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wallis CJD, Glaser A, Hu JC, Huland H,
Lawrentschuk N, Moon D, Murphy DG, Nguyen PL, Resnick MJ and Nam
RK: Survival and Complications Following Surgery and Radiation for
Localized Prostate Cancer: An International Collaborative Review.
Eur Urol. 73:11–20. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nepple KG, Stephenson AJ, Kallogjeri D,
Michalski J, Grubb RL III, Strope SA, Haslag-Minoff J, Piccirillo
JF, Ciezki JP, Klein EA, et al: Mortality after prostate cancer
treatment with radical prostatectomy, external-beam radiation
therapy, or brachytherapy in men without comorbidity. Eur Urol.
64:372–378. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wallis CJD, Saskin R, Choo R, Herschorn S,
Kodama RT, Satkunasivam R, Shah PS, Danjoux C and Nam RK: Surgery
Versus Radiotherapy for Clinically-localized Prostate Cancer: A
Systematic Review and Meta-analysis. Eur Urol. 70:21–30. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Epstein JI, Allsbrook WC Jr, Amin MB and
Egevad LL: Update on the Gleason grading system for prostate
cancer: Results of an international consensus conference of
urologic pathologists. Adv Anat Pathol. 13:57–59. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kibel AS, Ciezki JP, Klein EA, Reddy CA,
Lubahn JD, Haslag-Minoff J, Deasy JO, Michalski JM, Kallogjeri D,
Piccirillo JF, et al: Survival among men with clinically localized
prostate cancer treated with radical prostatectomy or radiation
therapy in the prostate specific antigen era. J Urol.
187:1259–1265. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sooriakumaran P1, Nyberg T, Akre O,
Haendler L, Heus I, Olsson M, Carlsson S, Roobol MJ, Steineck G and
Wiklund P: Comparative effectiveness of radical prostatectomy and
radiotherapy in prostate cancer: observational study of mortality
outcomes. BMJ. 26:348:g15022014.
|
|
11
|
Concato J, Shah N and Horwitz RI:
Randomized, controlled trials, observational studies, and the
hierarchy of research designs. N Engl J Med. 342:1887–1892. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Donovan JL, Lane JA, Peters TJ, Brindle L,
Salter E, Gillatt D, Powell P, Bollina P, Neal DE and Hamdy FC;
ProtecT Study Group, : Development of a complex intervention
improved randomization and informed consent in a randomized
controlled trial. J Clin Epidemiol. 62:29–36. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cooperberg MR, Vickers AJ, Broering JM and
Carroll PR: Comparative risk-adjusted mortality outcomes after
primary surgery, radiotherapy, or androgen-deprivation therapy for
localized prostate cancer. Cancer. 116:5226–5234. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wallace K, Fleshner N, Jewett M, Basiuk J
and Crook J: Impact of a multi-disciplinary patient education
session on accrual to a difficult clinical trial: The Toronto
experience with the surgical prostatectomy versus interstitial
radiation intervention trial. J Clin Oncol. 24:4158–4162. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cookson MS, Aus G, Burnett AL,
Canby-Hagino ED, D'Amico AV, Dmochowski RR, Eton DT, Forman JD,
Goldenberg SL, Hernandez J, et al: Variation in the definition of
biochemical recurrence in patients treated for localized prostate
cancer: The American Urological Association Prostate Guidelines for
Localized Prostate Cancer Update Panel report and recommendations
for a standard in the reporting of surgical outcomes. J Urol.
177:540–545. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Roach M III, Hanks G, Thames H Jr,
Schellhammer P, Shipley WU, Sokol GH and Sandler H: Defining
biochemical failure following radiotherapy with or without hormonal
therapy in men with clinically localized prostate cancer:
Recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int
J Radiat Oncol Biol Phys. 65:965–974. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Walsh PC: Anatomic radical prostatectomy:
Evolution of the surgical technique. J Urol. 160:2418–2424. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Merrick GS, Butler WM, Dorsey AT, Lief JH
and Benson ML: Seed fixity in the prostate/periprostatic region
following brachytherapy. Int J Radiat Oncol Biol Phys. 46:215–220.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Heidenreich A, Bastian PJ, Bellmunt J,
Bolla M, Joniau S, van der Kwast T, Mason M, Matveev V, Wiegel T,
Zattoni F, et al European Association of Urology, : EAU guidelines
on prostate cancer. part 1: Screening, diagnosis, and local
treatment with curative intent-update 2013. Eur Urol. 65:124–137.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Therneau TM and Grambsch PM: Modeling
Survival Data: Extending the Cox Model. Springer; New York, NY:
2000, View Article : Google Scholar
|
|
21
|
Hannoun-Lévi JM: Brachytherapy for
prostate cancer: Present and future. Cancer Radiother. 21:469–472.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Prada PJ, González H, Fernández J, Jiménez
I, Iglesias A and Romo I: Biochemical outcome after high-dose-rate
intensity modulated brachytherapy with external beam radiotherapy:
12 years of experience. BJU Int. 109:1787–1793. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kupelian PA, Potters L, Khuntia D, Ciezki
JP, Reddy CA, Reuther AM, Carlson TP and Klein EA: Radical
prostatectomy, external beam radiotherapy <72 Gy, external beam
radiotherapy > or =72 Gy, permanent seed implantation, or
combined seeds/external beam radiotherapy for stage T1-T2 prostate
cancer. Int J Radiat Oncol Biol Phys. 58:25–33. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ciezki JP, Weller M, Reddy CA, Kittel J,
Singh H, Tendulkar R, Stephans KL, Ulchaker J, Angermeier K,
Stephenson A, et al: A comparison between low-dose-rate
brachytherapy with or without androgen deprivation, external beam
radiation therapy with or without androgen deprivation, and radical
prostatectomy with or without adjuvant or salvage radiation therapy
for high-risk prostate cancer. Int J Radiat Oncol Biol Phys.
97:962–975. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ciezki JP: High-risk prostate cancer in
the modern era: Does a single standard of care exist? Int J Radiat
Oncol Biol Phys. 87:440–442. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
D'Amico AV, Whittington R, Malkowicz SB,
Schultz D, Blank K, Broderick GA, Tomaszewski JE, Renshaw AA,
Kaplan I, Beard CJ, et al: Biochemical outcome after radical
prostatectomy, external beam radiation therapy, or interstitial
radiation therapy for clinically localized prostate cancer. JAMA.
280:969–974. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Klein EA, Ciezki J, Kupelian PA and
Mahadevan A: Outcomes for intermediate risk prostate cancer: Are
there advantages for surgery, external radiation, or brachytherapy?
Urol Oncol. 27:67–71. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Colberg JW, Decker RH, Khan AM, McKeon A,
Wilson LD and Peschel RE: Surgery versus implant for early prostate
cancer: Results from a single institution, 1992–2005. Cancer J.
13:229–232. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Taussky D, Ouellet V, Delouya G and Saad
F: A comparative study of radical prostatectomy and permanent seed
brachytherapy for low- and intermediate-risk prostate cancer. Can
Urol Assoc J. 10:246–250. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ferreira AS, Guerra MR, Lopes HE, Lima UT,
Vasconcelos YA and Teixeira MT: Brachytherapy and radical
prostatectomy in patients with early prostate cancer. Rev Assoc Med
Bras. 61:431–439. 2015.doi.org/10.1590/1806-9282.61.05.431.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Holmberg L, Bill-Axelson A, Helgesen F,
Salo JO, Folmerz P, Häggman M, Andersson SO, Spångberg A, Busch C,
Nordling S, et al Scandinavian Prostatic Cancer Group Study Number
4, : A randomized trial comparing radical prostatectomy with
watchful waiting in early prostate cancer. N Engl J Med.
347:781–789. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Matzkin H, Perito PE and Soloway MS:
Prognostic factors in metastatic prostate cancer. Cancer. 72
(Suppl):3788–3792. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lindberg C, Davidsson T, Gudjónsson S,
Hilmarsson R, Liedberg F and Bratt O: Extended pelvic
lymphadenectomy for prostate cancer: Will the previously reported
benefits be reproduced in hospitals with lower surgical volumes?
Scand J Urol Nephrol. 43:437–441. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nakashima J, Kikuchi E, Miyajima A,
Nakagawa K, Oya M, Ohigashi T and Murai M: Simple stratification of
survival using bone scan and serum C-reactive protein in prostate
cancer patients with metastases. Urol Int. 80:129–133. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Joly F and Henry-Amar M: Prognostic
factors of localised, locally advanced or metastatic prostate
cancer. Bull Cancer. 94 (Suppl):35–43. 2007.
|
|
36
|
Kakehi Y: Watchful waiting as a treatment
option for localized prostate cancer in the PSA era. Jpn J Clin
Oncol. 33:1–5. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Leong N, Pai HH, Morris WJ, Keyes M,
Pickles T, Tyldesley S and Wu J: British Columbia Cancer Agency:
Rectal ulcers and rectoprostatic fistulas after (125)I low dose
rate brachytherapy. J Urol. 195:1811–1816. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Jarosek SL, Virnig BA, Chu H and Elliott
SP: Propensity-weighted long-term risk of urinary adverse events
after prostate cancer surgery, radiation, or both. Eur Urol.
67:273–280. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Pardo Y, Guedea F, Aguiló F, Fernández P,
Macías V, Mariño A, Hervás A, Herruzo I, Ortiz MJ, Ponce de León J,
et al: Quality-of-life impact of primary treatments for localized
prostate cancer in patients without hormonal treatment. J Clin
Oncol. 28:4687–4696. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Buron C, Le Vu B, Cosset JM, Pommier P,
Peiffert D, Delannes M, Flam T, Guerif S, Salem N, Chauveinc L, et
al: Brachytherapy versus prostatectomy in localized prostate
cancer: Results of a French multicenter prospective medico-economic
study. Int J Radiat Oncol Biol Phys. 67:812–822. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lardas M, Liew M, van den Bergh RC, De
Santis M, Bellmunt J, Van den Broeck T, Cornford P, Cumberbatch MG,
Fossati N, Gross T, et al: Quality of Life Outcomes after Primary
Treatment for Clinically Localised Prostate Cancer: A Systematic
Review. Eur Urol. 72:869–885. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chen RC, Basak R, Meyer AM, Kuo TM,
Carpenter WR, Agans RP, Broughman JR, Reeve BB, Nielsen ME, Usinger
DS, et al: Association between choice of radical prostatectomy,
external beam radiotherapy, brachytherapy, or active surveillance
and patient-reported quality of life among men with localized
prostate cancer. JAMA. 317:1141–1150. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Giberti C, Chiono L, Gallo F, Schenone M
and Gastaldi E: Radical retropubic prostatectomy versus
brachytherapy for low-risk prostatic cancer: A prospective study.
World J Urol. 27:607–612. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Cooperberg MR, Grossfeld GD, Lubeck DP and
Carroll PR: National practice patterns and time trends in androgen
ablation for localized prostate cancer. J Natl Cancer Inst.
95:981–989. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Koo KC, Cho JS, Bang WJ, Lee SH, Cho SY,
Kim SI, Kim SJ, Rha KH, Hong SJ and Chung BH: Cancer-specific
mortality among Korean men with localized or locally advanced
prostate cancer treated with radical prostatectomy versus
radiotherapy: A multi-center study using propensity scoring and
competing risk regression analyses. Cancer Res Treat. 50:129–137.
2018. View Article : Google Scholar : PubMed/NCBI
|
